A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease
- 1 March 2012
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Aging
- Vol. 33 (3), 624.e11-624.e22
- https://doi.org/10.1016/j.neurobiolaging.2011.03.004
Abstract
No abstract availableKeywords
Funding Information
- Istituto Superiore di Sanità
- Rete Italiana Chimica Farmaceutica CHEM-PROFARMA-NET (RBPR05NWWC)
This publication has 53 references indexed in Scilit:
- Diagnostic and Statistical Manual of Mental DisordersPsychiatry Research, 2011
- Attenuation of AD‐like neuropathology by harnessing peripheral immune cells: local elevation of IL‐10 and MMP‐9Journal of Neurochemistry, 2009
- PD‐1 signaling in primary T cellsImmunological Reviews, 2009
- Aβ aggregation and possible implications in Alzheimer's disease pathogenesisJournal of Cellular and Molecular Medicine, 2009
- Myelin basic protein-specific T lymphocytes proliferation and programmed cell death in demyelinating diseasesClinical Immunology, 2008
- Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathologyNature Medicine, 2008
- Peripheral inflammatory mechanisms modulate microglial activation in response to mild impairment of oxidative metabolismNeurochemistry International, 2006
- PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infectionThe Journal of Experimental Medicine, 2006
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982